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ABSTRACT
Background. Using the theoretical framework of the Self Regulation Model (SRM), many studies
have demonstrated that beliefs individuals hold about their physical health problems are important
in predicting health outcomes. This study tested the SRM in the context of a mental health problem,
schizophrenia.
Method. One hundred and twenty-four people with a diagnosis of schizophrenia were assessed on
measures of symptom severity, beliefs about their mental health problems, coping and appraisal
of outcome at two time points, 6 months apart.
Results. Using multivariate analyses and controlling for severity of symptoms, beliefs about
mental health were found to be significant predictors of outcome. Beliefs about greater negative
consequences were the strongest and most consistent predictors of a poorer outcome in both cross-
sectional and longitudinal analyses.
Conclusions. These results suggest that the SRM is a promising model for mental health prob-
lems and may highlight important areas for development in clinical, and especially psychosocial
interventions.
INTRODUCTION
In physical health research many social cog-
nition models have been proposed to identify
key beliefs mediating the impact of disease
factors on emotional and behavioural respon-
ses (Connor & Norman, 1995). Overall, these
models have shown that beliefs about illness
account for significant variance in outcome ap-
praisal and are amenable to change. These find-
ings offer important opportunities for clinical
interventions.
The Self Regulation Model (SRM; Leventhal
et al. 1984) assumes that people are problem
solvers whose health-related behaviours are at-
tempts to close the perceived gap between their
current health and their future goal state. The
model proposes that coping strategies are guided
by interpretation of illness experiences. Indi-
viduals constantly appraise their outcome in
relation to their desired health state and modify
their beliefs and behaviour accordingly.
The SRM hypothesizes that beliefs about
identity, cause, consequences, timeline and the
potential for control/cure are the key beliefs
guiding responses. These beliefs can be assessed
using the Illness Perception Questionnaire (IPQ;
Weinman et al. 1996). The recent Illness Per-
ception Questionnaire Revised (IPQR; Moss-
Morris et al. 2001), includes additional sub-
scales : ‘ timeline cyclical ’ (how variable the
symptoms are) and ‘coherence ’ (how much in-
dividuals believe they understand their illness).
The control dimension has been divided into
personal and treatment control, and a dimen-
sion to assess the ‘emotional ’ response of the
individual has been added. IPQR is explicitly
designed to be modified to suit particular ill-
nesses and for research use.
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Outcome appraisal is defined as perceptions
of current health state and has been assessed in
various ways, the most common focusing on the
individuals’ perceived quality of life, emotional
state or current level of functioning. These foci
recognize the broad impact of physical health
problems. In studies into schizophrenia, the
main outcome is often symptom severity but
this may not always be the most desirable out-
come from the patients’ perspective. A more
psychological perspective, in which the ultimate
aim is to reduce distress, suggests that emotional
state, quality of life, satisfaction and function-
ing are important outcome variables ; therefore
these are used as measures of outcome appraisal
in this study. Recent work by Birchwood et al.
(1993, 2000) suggests that for some people with
schizophrenia, an increase in emotional distress
occurs after the remission of psychotic symp-
toms, and can be predicted by negative ap-
praisals of this experience. Therefore, at least
some variance in distress is associated with
appraisals of psychosis rather than directly due
to the psychotic process. This study attempts




Participants were identified via Community
MentalHealthTeams.Diagnosiswas taken from
a systematic chart review using a checklist of
diagnostic criteria based on DSM-IV (APA,
1994). Information about prescribedmedication,
length of contact with services and recent his-
tory of symptom fluctuations was taken from
hospital notes.
Measures
All assessments were conducted by the first
author (F.L.) or a research assistant.
Symptom severity
The Positive and Negative Syndrome Scale
(PANSS; Kay et al. 1989) is widely used as a
measure of symptom severity in schizophrenia
and has acceptable levels of reliability and val-
idity (Kay et al. 1989). A total of the positive
and negative subscale scores was used in this
study. The general subscale was not used as it
has been shown to be less reliable (Purnine et al.
2000) and includes items that are confounded
with appraisal of outcome (e.g. anxiety and
depression). Each interviewer’s reliability was
assessed by comparing ratings of 10 interviews
with those of an experienced consultant psy-
chiatrist. Intra-class correlations suggested good
inter-rater reliability (0.83–0.95).
Coping
Coping was assessed using a structured inter-
view in conjunction with the PANSS. For each
item identified as a problem by the rater (a score
of 4+ on the PANSS), participants were asked
about their primary appraisal of the experience,
i.e. whether or not they perceived this to be a
problem. If they did, they were asked to describe
what coping strategies they used. Positive and
negative strategies were defined by the taxonomy
reported by Tarrier (1987) and Tarrier et al.
(1993). Classifications were made by the first
author (F.L.) and a Professor of Psychology
(C.H.) that were highly reliable with each other
(kappa=0.88), and participants were categor-
ized into the following variables for use in the
analysis.
(1) Positive coping. 1=participant did not
perceive any problems; 2=problems were per-
ceived but a low frequency of positive strategies
were reported (mean of less than two per prob-
lem); 3=problems were perceived and a high
frequency of positive strategies were reported
(mean of two or more per problem).
(2) Negative coping. 1=participant did not
perceive any problems; 2=problems were per-
ceived but no negative strategies reported;
3=problems were perceived and negative strat-
egies used.
Beliefs about mental health problems
The Illness Perception Questionnaire for
Schizophrenia (IPQS)
A modified version of the IPQR was used to
assess beliefs about mental health problems.
Adaptations were based on extensive qualitative
interviews with people diagnosed with schizo-
phrenia (Lobban & Barrowclough, unpublished
observations). Alphas for the subscales ranged
from 0.68 to 0.87, and all showed good test–
retest reliability (range=0.57–0.95) (Lobban
et al. in press). The subscales are summarized
below and the items are listed in the Appendix.
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(1) Identity (58 items). Fifty-eight mental
health experiences associated with schizophrenia
were listed including positive symptoms, nega-
tive symptoms, affective symptoms, and side
effects of medication. For each item participants
were asked to indicate whether or not they had
experienced this, and whether they attributed it
to amental health problem, effects ofmedication,
and/or other factors. The remaining subscales
all consisted of statements that were scored be-
tween 1 (=strongly disagree) and 5 (=strongly
agree).
(2) Timeline acute/chronic (6 items).
(3) Timeline cyclical (4).
(4) Consequences (11).
(5) Personal control (4).
(6) Treatment control (5).
(7) Coherence (5).
High scores denote a more chronic and cycli-
cal timeline, greater perceived negative conse-
quences, greater perceived personal control and
belief in treatment, and a sense of having a less
coherent understanding. Although a causal sub-
scale is included in the IPQS, the items were not
easily classified into meaningful dimensions and
are therefore not reported.
Outcome measures
(1) Hospital Anxiety and Depression Scale
(HADS; Zigmund & Snaith, 1983) consists of
14 items (7 for anxiety, 7 for depression), all
of which are scored 0–3.
(2) The Manchester Short Assessment of
Quality of Life (Priebe et al. 1999) is a condensed
and slightly modified version of the Lancashire
Quality of Life Profile (Oliver et al. 1991). Two
scores were used: mean quality of life (QL) and
satisfaction with mental health (SMH), each
rated on an 8-point scale.
(3) Global Assessment of Functioning (GAF;
APA, 1994) is a measure of overall psychologi-
cal disturbance rated by the interviewer. Only
the GAF disability score was used in the main
analysis. Reliability of the interviewers was as-
sessed using a sub-sample of 10 participants
who were rated by all three raters. The intra-
class correlation r=0.74 (p<0.01), suggested
adequate inter-rater reliability.
Statistical analysis
Not all participants completed all items. There-
fore, the exact n for each of the statistical tests
is reported. Descriptive statistics are presented
for all measures followed by univariate associ-
ations between beliefs, coping and outcomes.
Multiple regression analyses were then used to
identify which of the independent variables were
the best predictors of the outcome variables
both cross-sectionally at each time point and
longitudinally. Only variables that were univari-
ately associated with each outcome variable
(p<0.05) at either time point were included in
the regression. Patient characteristics were en-
tered into the first block using forward selection.
Symptom severity was forced into the second
block to ensure that this was always controlled
for. Beliefs about mental health problems were
entered into block three using forward selection.
Finally coping strategies were entered into block
four using forward selection. The categorical
coping variables were coded as two dummy
variables, the first indicating whether or not a
problem was perceived (primary appraisal) and
the second indicating whether or not a particu-
lar coping style was used.
Despite multiple testing, a statistical signifi-
cance level of p<0.05 was chosen for interpret-
ing the results. Given the exploratory nature of
the study, the risk of making a type II error was
considered more detrimental to future research
than a type I error.
RESULTS
Patient characteristics
A total of 175 people were identified as eligible
and invited into the study. Fifty-one declined,
leaving a total sample size of 124 (response
rate=71%). Participants were interviewed at
two time points approximately 6 months apart
(mean=197.59 days, S.D.=77.95 days). Twenty-
two people (17.7%) declined to be interviewed
at time 2. They did not differ significantly from
those who were retained on any of the variables.
A total of 94% of the sample (n=116) had a
diagnosis of schizophrenia (n=105), or schizo-
affective disorder (n=11). The rest had a diag-
nosis of psychosis (n=5), paranoid psychosis
(n=2) or delusional disorder (n=1). The mean
age of the sample was 38.81 years (S.D.=10.44
years). The average length of contact with
mental health services was 12.05 years (S.D.=
8.65 years). A total of 32% (n=40) of the sample
were receiving regular depot medication and
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78% (n=97) were receiving oral antipsychotic
medication (most commonly atypicals). All
psychotic symptoms had been stable for at least
6 weeks. The mean premorbid IQ assessed
using the National Adult Reading Test was 97
(S.D.=16).
Symptom severity
The mean score on the PANSS positive subscale
was 15.12 (S.D.=5.07) and on the negative sub-
scale was 13.12 (S.D.=4.82). There was no sig-
nificant difference between the PANSS score at
time 1 and time 2 (t=1.454, df=101, p=0.149).
Beliefs about mental health problems
Table 1 shows mean scores per item on the
IPQS. People reported experiencing well over
half the symptoms listed. The majority of these
were attributed to a mental health problem.
People generally viewed their problems as
chronic, cyclical and having high negative conse-
quences. They felt they had some personal con-
trol over their symptoms and that treatment
could offer some control. In general, people felt
they had a coherent understanding of their men-
tal health problems. There were no significant
differences between scores at time 1 and time 2
on any IPQS subscales.
Coping strategies
Forty-two per cent of participants’ primary ap-
praisal was of not having any problems (n=50)
at time 1 and they were categorized into group 1.
Of the remaining 74 people, 36 (29% of the total
sample) reported a high frequency of positive
coping strategies and 21 (17%) used negative
coping strategies.
At time 2, there was an increase in the pro-
portion of people who did not perceive any
problems.
Outcome measures
The mean score on HADS anxiety was 9.22
(S.D.=4.50). The mean depression score was
7.86 (S.D.=4.34).
The mean overall quality of life rating was
4.36 (S.D.=0.85), which reflects ‘neither satisfied
nor dissatisfied’. Satisfaction with mental health
had a mean score of 3.63 (S.D.=1.54), suggest-
ing that overall the sample were less satisfied
with their mental health than with other aspects
of their lives.
The mean score on the GAF disability sub-
scale was 48.28 (S.D.=11.30). This is consistent
with ‘serious impairment in social, occupational,
or school functioning’.
There were no significant differences between
scores at time 1 and time 2 on any of these
measures.
Univariate analyses
Beliefs about mental health problems and coping
strategies
Table 1 shows the results of ANOVAs to com-
pare the three groups of people using different
coping styles on each of the belief dimensions
Table 1. Mean scores on beliefs about mental health problems, and comparison across coping
styles at time 1 and time 2 [F values (p value)]
IPQS subscale (n in each analysis)

















Identity 58 items; mean total (n=113) 35.10 (11.7) 10.74*** 14.39*** 36.56 (12.54) 1.52 1.91
Proportion attributed to mental health (n=113) 0.63 0.73 1.09 0.64 (0.28) 0.05 0.34
Proportion attributed to medication (n=113) 0.14 0.21 0.11 0.154 (0.15) 0.85 0.85
Proportion attributed to other factors (n=113) 0.31 0.45 0.50 0.29 (0.27) 0.28 1.37
Timeline acute/chronic (n=109) 3.53 (0.76) 4.74* 4.69* 3.49 (0.76) 1.37 1.45
Timeline cyclical (n=111) 3.77 (0.65) 7.43** 5.88** 3.79 (0.67) 0.61 1.56
Consequences (n=111) 3.43 (0.58) 2.40 3.40* 3.44 (0.60) 1.01 0.62
Personal control (n=109) 3.48 (0.70) 13.00*** 16.12*** 3.48 (0.66) 0.79 2.15
Treatment control (n=111) 3.53 (0.64) 7.95** 2.63 3.55 (0.65) 0.88 0.02
Coherence (n=112) 2.70 (0.69) 3.41* 1.56 2.65 (0.70) 0.23 1.78
IPQS, the Illness Perception Questionnaire for Schizophrenia.
Significance levels: * p<0.05; ** p<0.01; *** p<0.001.
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at time 1 and time 2. Significant differences at
p<0.05 were further explored using Gabriel’s
post-hoc tests to control for unequal group sizes.
Positive coping strategies. At time 1 participants
whose primary appraisal was of not having any
problems (group 1) reported fewer symptoms,
a more acute and less cyclical timeline, greater
belief in treatment to control symptoms, and a
more coherent understanding of their mental
health problems than at least one of the other
two groups. Among those who did perceive a
problem, high frequency of positive coping
strategies (group 3) was associated with an in-
creased perception of personal control than
those who reported few positive coping strate-
gies (group 2, p=0.002). At time 2 there were
no significant differences between any of the
groups.
Negative coping strategies. At time 1 partici-
pants whose primary appraisal was of not per-
ceiving any problems (group 1) had the most
acute and least cyclical timelines for their symp-
toms, and believed that they had greater control
over their symptoms. There were no significant
differences between the groups distinguished by
their use of negative coping styles on these sub-
scales. Use of negative coping strategies was
positively associated with increased identity
scores (p=0.028), and more negative conse-
quences (p=0.044). At time 2 there were no sig-
nificant differences between any of the groups.
Associations between independent variables and
outcome measures
Univariate relationships between the indepen-
dent variables (patient characteristics, symptom
severity, beliefs and coping) and dependent vari-
ables (outcome appraisal measures) are shown
in Tables 2 and 3. None of the patient charac-
teristics was directly associated with the out-
come appraisal measures at time 1, but at time
2 being female was associated with a higher
GAF score. Symptom severity was associated
with poorer outcome appraisal on all measures
at both time points. All belief dimensions were
associated with at least one of the outcome ap-
praisal measures. Poorer outcome appraisal was
consistently associated with a stronger identity,
a more chronic and more cyclical timeline,
greater perceived negative consequences, less
control and less sense of a coherent under-
standing of mental health problems at both time
points.
Outcomes also significantly differed between
groups on the coping variables at time 1. Most
of these differences were between groups who
differed in their primary appraisal. However,
people who did perceive a problem and who also
Table 2. Associations between independent variables (patient characteristics, symptom severity,
beliefs, and coping) and dependent variables (outcome appraisal measures) at time 1 (n=109–124)
Independent variables HADS anxiety HADS depression QL SMH GAF disability
Age 0.02 0.13 x0.14 x0.11 x0.17
Sex (t value) x0.44 0.05 x1.79 x0.23 x1.87
Length of contact with services 0.08 x0.03 x0.05 x0.09 x0.09
PANSS pos+neg 0.34** 0.27** x0.42** x0.32** x0.46**
Identity 0.36** 0.27** x0.29** x0.28** x0.20*
Attributed to mental health problems 0.19* 0.09 x0.10 x0.18 x0.09
Attributed to medication side effects x0.09 x0.13 0.06 0.11 0.19*
Attributed to other factors x0.18 x0.06 0.04 0.21* x0.06
Timeline acute/chronic 0.31** 0.28** x0.24* x0.30** x0.27**
Timeline cyclical (non-parametric) 0.372** 0.452** x0.263** x0.190* x0.155
Consequences 0.47** 0.54** x0.61** x0.48** x0.41**
Personal control x0.17 x0.14 0.26** 0.30** 0.30**
Treatment control (non-parametric) x0.23* x0.26** 0.32** 0.35** 0.28**
Coherence 0.13 0.32** x0.22* x0.23* x0.20*
Positive coping strategies (F value) 16.42** 7.84** 29.01** 21.15** 16.25**
Negative coping strategies (F value) 16.70** 10.86** 32.35** 21.48** 21.66**
GAF, Global Assessment of Functioning; HADS, the Hospital Anxiety and Depression Scale ; QL, quality of life ; SMH, satisfaction with
mental health.
Significance levels : * p<0.05; ** p<0.01.
All values are Pearson’s correlations except for variables labeled (non-parametric) where Spearman’s correlations are shown, and for coping
variables where the F value for one-way ANOVA is given.
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used negative strategies had poorer perceived
quality of life (p=0.032) and were rated as less
able on the GAF (p=0.013) than those who
perceived a problem but did not use negative
strategies.
All of the significant differences at time 2 were
due to differences between those who perceived
a problem and those who did not rather than
differences in use of specific coping strategies.
Multivariate analysis
Table 4 shows the results of the regression
analyses with the outcome appraisal measures
as the dependent variables at time 1. All the
analyses were repeated on the data collected at
time 2 to test the reliability of the findings and
the results are described in the text below. Longi-
tudinal analyses were also performed in which
time 1 independent variables were used to pre-
dict outcome scores at time 2 (see Table 5).
Scores on the outcome appraisal measures at
time 1 were controlled for by entering them
into an additional first block in the regression
analysis.
To check how well the regression equations
fitted the data, the standardized residuals were
checked. None had an absolute value greater
than three, suggesting adequate fit of the data
(Field, 2000).
HADS anxiety
Symptoms alone were able to account for
11.3% of the variance in anxiety at time 1. With
the addition of beliefs about symptoms, this in-
creased to 34.2%. High negative consequences,
strong identity and lack of faith in the ability of
treatment approaches to control symptoms were
all associated with higher anxiety, though treat-
ment control became non-significant in the final
model. The addition of coping failed to account
for any additional variance.
Cross-sectional analysis of data collected at
time 2 showed consistent findings over time. The
total adjusted R2 was 43.5%. Direct significant
predictors were consequences [standardized beta
(sb)=0.303], identity (sb=0.290), and treatment
control (sb=x0.307). Symptom severity just
failed to reach significance (p=0.061). Coping
failed to account for any additional variance at
time 2.
The longitudinal analysis showed that the
only significant predictor of anxiety at time 2
was anxiety at time 1. This accounted for 46.1%
of the variance.
HADS depression
Severity of symptoms explained 7.6% of the
variance in depression at time 1. With the ad-
dition of beliefs about mental health problems,
Table 3. Associations between independent variables (patient characteristics, symptom severity,
beliefs, and coping) and dependent variables (outcome appraisal measures) at time 2 (n=84–102)
Independent variables HADS anxiety HADS depression QL SMH GAF
Age x0.05 0.19 x0.14 x0.11 x0.07
Sex (t value) x0.58 1.67 x0.96 x0.93 x2.07*
Length of contact with services 0.01 x0.04 x0.01 x0.07 x0.03
PANSS pos+neg 0.32** 0.29** x0.32** x0.40** x0.43**
Identity x0.05 0.36** x0.34** x0.30** x0.22
Attributed to mental health problems 0.22* 0.16 x0.14 x0.19 0.06
Attributed to medication side effects x0.05 x0.14 0.26* 0.14 0.11
Attributed to other factors x0.13 x0.15 0.03 0.15 x0.08
Timeline acute/chronic 0.35** 0.44** x0.13 x0.36** x0.23*
Timeline cyclical (non-parametric) 0.45** 0.25* x0.18 x0.30** x0.20
Consequences 0.52** 0.58** x0.54** x0.53** x0.34**
Personal control 0.15 x0.21* 0.14 0.27* 0.18
Treatment control x0.47** x0.34** 0.453** 0.34** 0.24*
Coherence 0.18 0.37** x0.23* x0.24* x0.14
Positive coping strategies (F value) 4.32* 0.38 2.03 4.15* 4.17*
Negative coping strategies (F value) 7.48** 0.69 1.59 5.00** 4.27*
GAF, Global Assessment of Functioning; HADS, the Hospital Anxiety and Depression Scale ; QL, quality of life ; SMH, satisfaction with
mental health.
Significance levels : * p<0.05; ** p<0.01.
All values are Pearson’s correlations except for variables labelled (non-parametric), where Spearman’s correlations are shown, and for
coping variables where the F value for one-way ANOVA is given.
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symptom level was no longer a significant pre-
dictor and the amount of variance explained
increased to 35.7%. A perception of high nega-
tive consequences and lack of coherence were
both associated with greater depression. Coping
did not account for any additional variance.
Cross-sectional analysis of the time 2 data
showed that, as at time 1, high negative
Table 4. Multiple regressions with outcome appraisal measures as dependent variables.
Cross-sectional analysis at time 1
Outcome variable
Independent variables in
the equation Beta (b) CI Beta sb Sig. (p=or<)
Adj. R2 with
variable added
HADS anxiety (n=109) PANSS pos+neg 0.086 0.001 to 0.173 0.163 0.048 0.113
Consequences 0.175 0.039 to 0.311 0.237 0.012 0.280
Identity 0.085 0.013 to 0.157 0.205 0.021 0.318
Treatment control x0.209 x0.448 to 0.030 x0.141 0.086 0.342
Emotion focused coping 2.465 0.732 to 4.197 0.246 0.006 0.385
HADS depression (n=111) PANSS pos+neg 0.055 x0.037 0.100 0.240 0.076
Consequences 0.345 0.220 0.469 0.001 0.316
Coherence 0.305 0.083 0.224 0.008 0.357
QL (n=108) PANSS pos+neg x0.019 x0.034 tox0.004 x0.186 0.013 0.238
Consequences x0.059 x0.079 tox0.040 x0.434 0.001 0.491
Personal control 0.046 0.005 to 0.086 0.147 0.028 0.515
Primary appraisal x0.552 x0.828 tox0.276 x0.306 0.001 0.578
SMH (n=108) PANSS pos+neg x0.022 x0.047 to 0.014 x0.088 0.289 0.144
Consequences x0.061 x0.103 tox0.019 x0.245 0.005 0.291
Personal control 0.076 x0.016 to 0.1269 0.136 0.104 0.342
Proportion of symptoms
attributed to other factors
1.419 0.397 tox2.381 0.214 0.010 0.364
Treatment control 0.096 0.010 to 0.182 0.192 0.029 0.384
Primary appraisal x1.154 x1.715 tox0.594 x0.353 0.001 0.470
GAF (n=107) PANSS pos+neg x0.376 x0.619 tox0.133 x0.269 0.003 0.217
Consequences x0.335 x0.655 tox0.015 x0.181 0.041 0.281
Personal control 0.640 x0.025 tox1.305 0.153 0.059 0.317
Proportion of symptoms attributed
to medication effects
16.137 2.780 to 29.494 0.187 0.018 0.342
Primary appraisal x6.780 x11.161 tox2.40 x0.280 0.003 0.393
GAF, Global Assessment of Functioning; HADS, the Hospital Anxiety and Depression Scale ; PANSS, the Positive and Negative
Syndrome Scale ; QL, quality of life ; SMH, satisfaction with mental health.
sb, Standardized beta.




the equation Beta (b) CI Beta sb Sig. (p=or<)
Adj. R2 with
variable added
HADS anxiety (n=102) HADS anxiety time 1 0.635 0.465 to 0.804 0.672 0.001 0.461
HADS depression (n=91) HAD depression time 1 0.552 0.376 to 0.729 0.593 0.001 0.489
PANSS pos+neg time 1 x0.028 x0.117 to 0.061 x0.051 0.534 0.483
Consequences time 1 0.149 0.019 to 0.278 0.218 0.025 0.509
QL (n=89) Quality of life time 1 0.399 0.181 to 0.618 0.394 0.001 0.480
PANSS pos+neg x0.0007 x0.018 to 0.019 0.006 0.894 0.474
Consequences time 1 x0.049 x0.075 tox0.023 x0.361 0.001 0.550
Negative coping strategies x0.407 x0.047 tox0.433 x0.177 0.027 0.572
SMH (n=91) SMH time 1 0.371 0.144 to 0.598 0.351 0.002 0.347
PANSS pos+neg time 1 0.032 x0.070 to 0.007 x0.152 0.104 0.365
Consequences time 1 x0.081 x0.134 tox0.028 x0.315 0.003 0.425
GAF disability (n=96) GAF disability time 1 0.795 0.670 to 0.921 0.833 0.001 0.689
GAF, Global Assessment of Functioning; HADS, the Hospital Anxiety and Depression Scale ; PANSS, the Positive and Negative
Syndrome Scale ; QL, quality of life ; SMH, satisfaction with mental health.
sb, Standardized beta.
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consequences (sb=0.381) and low coherence
(sb=0.333) were the strongest predictors of de-
pression. Greater symptom severity (sb=0.177)
and a more chronic perception of timeline (sb=
0.279) were also direct predictors of greater
depression at time 2. Coping did not account for
any additional variance.
In the longitudinal analysis time 1 depression
scores accounted for 48.9% of the variance
in depression scores at time 2. High negative
consequences at time 1 also significantly pre-
dicted later depression.
QL
Lower symptom severity score was associated
with higher QL and accounted for approxi-
mately 23.8% of the variance at time 1. With the
addition of beliefs about symptoms, the amount
of variance accounted for increased to 51.5%.
Perception of low negative consequences and
greater personal control predicted higher per-
ceived QL scores. Primary appraisal of not
having a problem increased the amount of vari-
ance explained a small but significant amount
to 57.8%.
The data at time 2 confirmed low negative
consequences as the main predictor of high QL
(sb=x0.555). Control was important again,
though high treatment control (sb=0.289)
was a stronger predictor of QL than personal
control at time 2. Neither coping nor symptom
severity were significant direct predictors of
QL at time 2.
In the longitudinal analysis quality of life at
time 2 was strongly predicted by quality of life
at time 1. However, perceived negative conse-
quences was also significant and increased the
amount of variance accounted for from 48.0%
to 55.0%. Negative coping was able to account
for a small but significant additional 2.2% of
variance.
Satisfaction with mental health (SMH)
Symptom severity was not a direct significant
predictor of SMH at time 1. Perception of low
negative consequences, greater treatment control
and attributing a higher proportion of symp-
toms to factors other than mental health prob-
lems or medication effects was associated with
increased SMH problems. These beliefs were
able to account for 38.4% of the variance.
Primary appraisal increased this to 47%. People
who did not perceive themselves as having any
problems reported higher satisfaction with their
mental health.
Time 2 analysis supported the important role
of beliefs about consequences in accounting for
the greatest amount of variance in SMH. How-
ever, symptom severity was a direct predictor
at time 2 (sb=x0.232). Symptoms accounted
for approximately 11.5% of the variance in
satisfaction, and beliefs about consequences
(sb=x0.496) increased this to 33.9%. Primary
appraisal and coping variables were unable to
account for any additional variance.
SMH at time 1 positively predicted satisfac-
tion at time 2 and accounted for approximately
34.7% of the variance. Higher perceived nega-
tive consequences at time 1 significantly pre-
dicted lower satisfaction at time 2 accounting
for an additional 7.8% of variance. Symptom
severity was not a significant predictor.
GAF-disability
Symptom severity accounted for 21.7% of the
variance in GAF scores with fewer symptoms
being associated with higher GAF ratings.
Beliefs about mental health problems increased
this to 34.2%with fewer perceived negative con-
sequences, and attributing a higher proportion
of symptoms to medication effects both being
associated with higher GAF ratings. Primary
appraisal increased the amount of variance ac-
counted for to 39.3%. People who did not per-
ceive themselves as having any problem received
higher GAF ratings.
Very similar results were found using the
time 2 data. Higher functioning was associated
with lower symptom severity (sb=x0.368), and
fewer negative consequences (sb=x0.305).
GAF scores were also higher for females than
for males (sb=0.205). Symptom severity ac-
counted for approximately 17% of the variance
and negative consequences increased this to
35.3%. None of the coping variables accounted
for any additional variance.
There was very little change in GAF
scores between time 1 and time 2. GAF ratings
at time 1 accounted for 68.9% of the vari-
ance in GAF ratings at time 2. None of the
other variables accounted for any additional
variance.
1172 F. Lobban et al.
DISCUSSION
The main findings from the study support the
SRM in showing that variation in beliefs about
mental health problems is associated with sig-
nificant variation in appraisal of outcome both
cross-sectionally and longitudinally.
In the cross-sectional analysis the amount of
variation accounted for by beliefs in anxiety
(22.9% at time 1–26.8% at time 2) and in
depression (28.1% at time 1–41.5% at time 2)
is directly comparable to that found in physi-
cal health studies using similar methodologies
(Rutter & Rutter, 2000; Edwards et al. 2001;
Fortune et al. 2002). In all of these studies be-
liefs about negative consequences were most
strongly associated with outcome. Coherence
was also an important predictor of depression in
this study but was not assessed in the physical
health studies. Perceived QL and SMH have
also been used as measures of outcome ap-
praisal in physical health. Rutter & Rutter
(2002) showed that for patients with IBS 26%
of variance in perceived QL (compared to
27.7–38.6% in this study) and 28% of variance
in satisfaction with mental health (compared to
24.0–22.4% in this study) could be accounted
for by illness beliefs with high negative conse-
quences again showing the strongest relation-
ship.
The GAF has not been used in previous
studies but was included here as a non self-
report measure in order to test whether relation-
ships between beliefs and outcome appraisal
were largely a function of them being from a
common source. The results from theGAF show
that beliefs accounted for significant amounts of
variance at both time points. As with the above
analyses, perceived negative consequences were
the strongest predictors of GAF ratings.
In this study we attempted to examine how
beliefs at one time point could be used to predict
outcome appraisal at a second time point.
However, there was very little change over the
6-month period in either beliefs about mental
health problems or outcome appraisal. Despite
this, perception of greater negative conse-
quences at time 1 did predict greater depression,
lower perceived quality of life, and less satisfac-
tion with mental health at time 2. The amounts
of variance accounted for by beliefs were small
(2% for depression, 7% for QL and 6% for
SMH) but comparable to those reported in
longitudinal studies in physical health (e.g.
Scharloo et al. 2000), suggesting that beliefs
about health problems are at least as important
in mental health as they are in physical health.
One reason for the amount of variance being so
small is that the outcome appraisal measures
are very general and therefore likely to be influ-
enced by variables other than those linked to
health, such as relationships, housing, work etc.
The clinical significance of the variance in
outcome appraisal accounted for by beliefs in
both physical and mental health problems is
unclear. Intervention studies are needed to test
both the causal mechanism of the relationship
between beliefs and outcome and the potential
to change this relationship in a way that has a
meaningful impact on peoples’ lives. Petrie et al.
(2002) reported the results of a Randomized
Controlled Trial using a three-session early in-
tervention to challenge illness perceptions fol-
lowing a myocardial infarction. They found a
reduction in negative beliefs, and reduced delay
in returning to work for the intervention group.
Intervention studies specifically focused on
challenging negative beliefs about mental health
problems have not yet been reported.
The assertion that coping mediates the re-
lationship between illness beliefs and outcome
appraisal was not supported in this study.
Beliefs had significant direct associations with
outcome appraisal and coping generally ac-
counted for little or no additional variance.
However, firm conclusions cannot be drawn as
there were considerable difficulties in accurately
measuring coping. In this study, the reduction
of specific strategies to categorical variables
measuring positive and negative strategies is
problematic in that fails to take into account the
effectiveness of strategies for the individual, how
consistently they are used, and the appropriate-
ness of strategies to different settings. Finally,
univariate associations between beliefs and
coping suggest some degree of shared variance
that is difficult to disentangle using these stat-
istical methods (though tolerance statistics were
checked to ensure that these associations were
not causing multi-colinearity in the analyses).
Despite these problems, the finding that
coping is not a mediator has potentially import-
ant implications of the mechanism underlying
the association between beliefs and outcome.
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The finding is consistent with a number of
physical health studies, which have failed to find
strong evidence for the importance of coping
(Moss-Morris et al. 1996; Heijmans, 1999;
Steed et al. 1999). These studies suggest that
rather than beliefs guiding attempts to cope,
which in turn impact on outcome appraisal as
the SRM suggests, beliefs about health prob-
lems may have a direct effect on the outcome.
This is consistent with a more general cognitive
models of psychosis as described by Morrison
(2001), Birchwood et al. (2000) and Garety et al.
(2001).
This study has several further limitations that
need to be taken into account when interpreting
the findings. The assessment of beliefs in this
study does not include some potentially im-
portant dimensions. Beliefs about the causes of
mental health problems and beliefs about per-
sonal responsibility and blame are assessed by
the IPQS, but did not form internally consistent
subscales and so were not used in this analysis
(Lobban et al. in press). The important role of
beliefs about specific treatments has also been
highlighted in previous literature (Horne &
Weinman, 1995), but were not assessed.
The longitudinal analysis in this study showed
little change over time. Future research may
focus on longer time periods and on events that
may be likely to be associated with change, such
as interventions, or relapse.
Finally, there are important differences be-
tween physical and mental health problems that
may limit the applicability of the SRM to psy-
chosis. The SRM assumes that people hold
models of illness in their heads that can be ac-
cessed by questioning. In psychosis, the nature
of the disorder may impair the ability or the need
to do this. In physical health problems there
may be a desire to identify a disease entity that
can be diagnosed and separated from the sense
of self. In psychosis the distinction between self
and illness is often more blurred and this may
make the ability to create an illness model more
difficult. The greater degree of stigma associated
with psychosis may increase the impact of the
social environment on the development and ex-
pression of beliefs in a way that is not currently
addressed in current applications of the SRM.
Despite these limitations, the results have
important clinical implications. They suggest
that the current focus on symptom severity as
a main outcome measure in clinical trials is
perhaps unwarranted. Symptom severity ac-
counted for some variance in outcome appraisal
for individuals in this study, but perceived con-
sequences, controllability and a sense of coher-
ence were also very important. This highlights
important opportunities for interventions that
aim to challenge negative appraisals using well
developed cognitive and behavioural therapies.
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APPENDIX
Timeline acute/chronic
My mental health problems will last a short time (R).
My mental health problems are likely to be permanent rather than temporary.
My mental health problems will last for a long time.
My mental health problems will pass quickly (R).
I expect to have these mental health problems for the rest of my life.
My mental health problems will improve in time (R).
Timeline cyclical
Sometimes I have more symptoms than other times.
I have times when I am well and times when I am not so well.
Sometimes the symptoms of my mental health problems are worse than other times.
Some of my symptoms will be there all the time but others will come and go.
Consequences
My mental health problem is a serious condition.
My mental health problems do not have much effect on my life (R).
My mental health problems have financial consequences for me.
My mental health problems make it more difficult for me to do day to day things.
My mental health problems cause difficulties for those who are close to me.
I don’t get on as well with our family since their mental health problems.
My mental health problems have messed up my social life.
My mental health problems mean that I am valued less by other people.
My mental health problems make working very difficult for me.
I have lost important relationships as a result of my mental health problems.
My mental health problems have had some positive effects on my life (R).
Personal control
There are some things that I can do to control my symptoms.
To some extent, what I do can determine whether my mental health problems get better or worse.
Nothing I do will affect my mental health problems (R).
My actions will have no effect on the outcome of my mental health problems (R).
Treatment control
There is little treatment available that can improve my mental health problems (R).
My treatment will be effective in managing my mental health problems.
The negative effects of my mental health problems can be prevented (avoided) by my treatment.
My treatment can control my mental health problems.
There is no treatment that can help with my condition (R).
Illness coherence
I feel very puzzled by my mental health problems.
I don’t have any understanding of my mental health problems at all.
I feel that I don’t know anything about my mental health problems.
My mental health problems make no sense to me at all.
I have a clear picture or understanding of my mental health problems (R).
(R)=reverse scored items.
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